* Modified release tablets.
* Composition: Each modified-release tablet contains:
Alfuzosin Hydrochloride 10 mg.
– Treatment of certain functional symptoms of benign prostatic hypertrophy, particularly if surgery has to be delayed for some reason.
– Adjuvant treatment to a catheter in acute urinary retention related to benign prostatic hypertrophy.
The recommended dosage is one 10-mg tablet per day, to be taken immediately after the evenning meal.
* Store in a dry place, at a temperature not exceeding 30 degrees C.
* Manufactured by: EVA PHARMA for Pharmaceuticals & Medical Appliances S.A.E – Egypt.